Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 8526975)

1.

Subanesthetic doses of ketamine stimulate psychosis in schizophrenia.

Lahti AC, Koffel B, LaPorte D, Tamminga CA.

Neuropsychopharmacology. 1995 Aug;13(1):9-19.

2.

Confidence and psychosis: a neuro-computational account of contingency learning disruption by NMDA blockade.

Vinckier F, Gaillard R, Palminteri S, Rigoux L, Salvador A, Fornito A, Adapa R, Krebs MO, Pessiglione M, Fletcher PC.

Mol Psychiatry. 2015 Jun 9. doi: 10.1038/mp.2015.73. [Epub ahead of print]

PMID:
26055423
3.

Ketamine-Induced Modulation of the Thalamo-Cortical Network in Healthy Volunteers As a Model for Schizophrenia.

Höflich A, Hahn A, Küblböck M, Kranz GS, Vanicek T, Windischberger C, Saria A, Kasper S, Winkler D, Lanzenberger R.

Int J Neuropsychopharmacol. 2015 Apr 19;18(9). pii: pyv040. doi: 10.1093/ijnp/pyv040.

4.

Optimizing the glutamatergic challenge model for psychosis, using S+ -ketamine to induce psychomimetic symptoms in healthy volunteers.

Kleinloog D, Uit den Boogaard A, Dahan A, Mooren R, Klaassen E, Stevens J, Freijer J, van Gerven J.

J Psychopharmacol. 2015 Apr;29(4):401-13. doi: 10.1177/0269881115570082. Epub 2015 Feb 17.

PMID:
25693889
5.

The effect of ketamine on configural facial processing.

MBSc EN, Joshua N, Morgan C, Rossell SL.

J Clin Psychopharmacol. 2015 Apr;35(2):188-91. doi: 10.1097/JCP.0000000000000278.

PMID:
25679135
6.

Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia.

Xu K, Krystal JH, Ning Y, Chen da C, He H, Wang D, Ke X, Zhang X, Ding Y, Liu Y, Gueorguieva R, Wang Z, Limoncelli D, Pietrzak RH, Petrakis IL, Zhang X, Fan N.

J Psychiatr Res. 2015 Feb;61:64-72. doi: 10.1016/j.jpsychires.2014.12.012. Epub 2014 Dec 24.

7.

Selective augmentation of striatal functional connectivity following NMDA receptor antagonism: implications for psychosis.

Dandash O, Harrison BJ, Adapa R, Gaillard R, Giorlando F, Wood SJ, Fletcher PC, Fornito A.

Neuropsychopharmacology. 2015 Feb;40(3):622-31. doi: 10.1038/npp.2014.210. Epub 2014 Aug 21.

PMID:
25141922
8.

The effects of subanesthetic ketamine infusions on motivation to quit and cue-induced craving in cocaine-dependent research volunteers.

Dakwar E, Levin F, Foltin RW, Nunes EV, Hart CL.

Biol Psychiatry. 2014 Jul 1;76(1):40-6. doi: 10.1016/j.biopsych.2013.08.009. Epub 2013 Sep 12.

9.

Glutamatergic dysbalance and oxidative stress in in vivo and in vitro models of psychosis based on chronic NMDA receptor antagonism.

Genius J, Geiger J, Dölzer AL, Benninghoff J, Giegling I, Hartmann AM, Möller HJ, Rujescu D.

PLoS One. 2013 Jul 15;8(7):e59395. doi: 10.1371/journal.pone.0059395. Print 2013.

10.

Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression.

Sos P, Klirova M, Novak T, Kohutova B, Horacek J, Palenicek T.

Neuro Endocrinol Lett. 2013;34(4):287-93.

PMID:
23803871
11.

Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept.

Rodriguez CI, Kegeles LS, Levinson A, Feng T, Marcus SM, Vermes D, Flood P, Simpson HB.

Neuropsychopharmacology. 2013 Nov;38(12):2475-83. doi: 10.1038/npp.2013.150. Epub 2013 Jun 19.

12.

Effects of pregabalin on behavioral alterations induced by ketamine in rats.

Nunes EA, Canever L, Oliveira Ld, Luca RD, Quevedo J, Zugno A, Peregrino A, Crippa JA, Dursun SM, Baker GB, Hallak JE.

Rev Bras Psiquiatr. 2012 Oct;34(3):329-33.

13.

Efficacy and safety of lurasidone 80 mg/day and 160 mg/day in the treatment of schizophrenia: a randomized, double-blind, placebo- and active-controlled trial.

Loebel A, Cucchiaro J, Sarma K, Xu L, Hsu C, Kalali AH, Pikalov A, Potkin SG.

Schizophr Res. 2013 Apr;145(1-3):101-9. doi: 10.1016/j.schres.2013.01.009. Epub 2013 Feb 13.

14.

The neurobehavioral pharmacology of ketamine: implications for drug abuse, addiction, and psychiatric disorders.

Trujillo KA, Smith ML, Sullivan B, Heller CY, Garcia C, Bates M.

ILAR J. 2011;52(3):366-78. doi: 10.1093/ilar.52.3.366.

15.

Impaired facial emotion recognition in a ketamine model of psychosis.

Ebert A, Haussleiter IS, Juckel G, Brüne M, Roser P.

Psychiatry Res. 2012 Dec 30;200(2-3):724-7. doi: 10.1016/j.psychres.2012.06.034. Epub 2012 Jul 7.

PMID:
22776754
16.

Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia.

D'Souza DC, Ahn K, Bhakta S, Elander J, Singh N, Nadim H, Jatlow P, Suckow RF, Pittman B, Ranganathan M.

Biol Psychiatry. 2012 Nov 1;72(9):785-94. doi: 10.1016/j.biopsych.2012.05.009. Epub 2012 Jun 19.

PMID:
22717030
17.

Effects of ketamine-induced psychopathological symptoms on continuous overt rhyme fluency.

Nagels A, Kirner-Veselinovic A, Wiese R, Paulus FM, Kircher T, Krach S.

Eur Arch Psychiatry Clin Neurosci. 2012 Aug;262(5):403-14. doi: 10.1007/s00406-011-0281-8. Epub 2011 Dec 22.

PMID:
22189657
18.

Glycine transporter inhibitor attenuates the psychotomimetic effects of ketamine in healthy males: preliminary evidence.

D'Souza DC, Singh N, Elander J, Carbuto M, Pittman B, Udo de Haes J, Sjogren M, Peeters P, Ranganathan M, Schipper J.

Neuropsychopharmacology. 2012 Mar;37(4):1036-46. doi: 10.1038/npp.2011.295. Epub 2011 Nov 23.

19.

Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.

Schmidt A, Bachmann R, Kometer M, Csomor PA, Stephan KE, Seifritz E, Vollenweider FX.

Neuropsychopharmacology. 2012 Mar;37(4):865-75. doi: 10.1038/npp.2011.261. Epub 2011 Oct 26.

20.

Repeated and escalating preoperative subanesthetic doses of ketamine for postoperative pain control in patients undergoing tumor resection: a randomized, placebo-controlled, double-blind trial.

Rakhman E, Shmain D, White I, Ekstein MP, Kollender Y, Chazan S, Dadia S, Bickels J, Amar E, Weinbroum AA.

Clin Ther. 2011 Jul;33(7):863-73. doi: 10.1016/j.clinthera.2011.05.094. Epub 2011 Jul 1.

PMID:
21722959
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk